Page last updated: 2024-10-24

cgp 12177 and Dementia

cgp 12177 has been researched along with Dementia in 1 studies

CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lemmer, B1
Langer, L1
Ohm, T1
Bohl, J1

Other Studies

1 other study available for cgp 12177 and Dementia

ArticleYear
Beta-adrenoceptor density and subtype distribution in cerebellum and hippocampus from patients with Alzheimer's disease.
    Naunyn-Schmiedeberg's archives of pharmacology, 1993, Volume: 347, Issue:2

    Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Alzheimer Disease; Binding, Competitive; Cereb

1993